Slingshot members are tracking this event:
Bridgebio's (BBIO) Infigratinib (BBP-831) in Cholangiocarcinoma PDUFA date Estimated for June 1, 2021, based on 6-month timeline
Slingshot Insights Explained
May 28, 2021
Don’t see a project related to the catalyst you care about?
Related Keywords Bbp-831, Infigratinib, Cholangiocarcinoma